Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.00001
-0.00009 (-90.00%)
At close: Aug 4, 2026
Iterum Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -26.96 | -24.77 | -38.37 | -44.43 | -91.56 | -52.01 |
Depreciation & Amortization | 1.32 | 0.28 | 1.75 | 1.8 | 2.1 | 0.16 |
Other Amortization | -1.21 | 2.29 | 2.34 | 2.34 | 4.1 | 10.93 |
Loss (Gain) From Sale of Investments | -0.35 | -0.35 | -1.15 | -0.18 | 0.64 | - |
Stock-Based Compensation | 0.26 | 0.36 | 0.78 | 22.11 | 4.32 | 2.76 |
Other Operating Activities | 10.28 | 8.15 | -7.45 | -2.41 | 65.01 | 8.19 |
Change in Accounts Payable | -0.26 | -4.75 | 2.22 | 1.9 | 0.06 | -14.67 |
Change in Income Taxes | 0.12 | 0.16 | 0.27 | -0.51 | 0.27 | -0.12 |
Change in Other Net Operating Assets | -1.12 | -8.14 | 0.27 | 0.93 | -0.77 | -9.77 |
Operating Cash Flow | -19.51 | -26.77 | -39.33 | -18.47 | -15.84 | -54.53 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.01 | -0 | -0.01 | -0.06 | -0.06 | -0.01 |
Investment in Securities | 1.1 | 18.21 | 23.35 | 14.02 | -54.53 | - |
Investing Cash Flow | 1.09 | 18.21 | 23.34 | 13.96 | -54.6 | -0.01 |
Long-Term Debt Issued | - | - | - | - | - | 0.74 |
Long-Term Debt Repaid | - | - | - | -2.25 | -6.52 | -6.23 |
Net Debt Issued (Repaid) | -14.75 | - | - | -2.25 | -6.52 | -5.49 |
Issuance of Common Stock | 30.79 | 26.69 | 1.03 | 0.43 | 89.64 | 58.37 |
Other Financing Activities | - | - | - | - | - | 11.59 |
Financing Cash Flow | 16.04 | 26.69 | 1.03 | -1.82 | 83.13 | 64.48 |
Foreign Exchange Rate Adjustments | -0.02 | -0.08 | -0.06 | -0.05 | 0 | -0.01 |
Net Cash Flow | -2.41 | 18.05 | -15.02 | -6.38 | 12.69 | 9.93 |
Free Cash Flow | -19.53 | -26.77 | -39.34 | -18.54 | -15.9 | -54.54 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -5007.18% | - | - | - | - | - |
Free Cash Flow Per Share | -0.53 | -1.36 | -3.04 | -1.51 | -1.46 | -34.07 |
Levered Free Cash Flow | -13.85 | -19.4 | -21.31 | -13.5 | -28.78 | -8.72 |
Unlevered Free Cash Flow | -11.29 | -20.11 | -22.75 | -14.37 | -30.04 | -11.96 |
Cash Interest Paid | - | - | - | 0.02 | 0.42 | 1 |
Cash Income Tax Paid | 0.12 | 0.22 | 0.4 | 0.82 | 0.44 | 0.12 |
Change in Working Capital | -2.85 | -12.73 | 2.76 | 2.31 | -0.44 | -24.56 |